Literature DB >> 32641317

Non-typeable Haemophilus influenzae and purpura fulminans.

Vivek Bhika Beechar1, Carolina de la Flor2, Richard J Medford2.   

Abstract

Haemophilus influenzae typically causes illness and infection in the paediatric population. We report a case of a 53-year-old man who developed invasive non-typeable H. influenzae infection associated with purpura fulminans and multiorgan failure. On review of the literature, this is the first reported case of non-typeable H. influenzae causing purpura fulminans. The patient was treated with intravenous ceftriaxone 2 g/day and was eventually discharged from the hospital almost 2 months after admission. We discuss the role that infection/sepsis plays in disturbances to the coagulation cascade leading to purpura fulminans and the virulence factors that make non-typeable H. influenzae unique. Finally, we review other cases of H. influenzae associated with purpura fulminans and discuss the similarities with our case. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  haematology (incl blood transfusion); infectious diseases; intensive care; pneumonia (infectious disease)

Mesh:

Year:  2020        PMID: 32641317      PMCID: PMC7348642          DOI: 10.1136/bcr-2020-234880

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Meropenem-induced liver injury and beta-lactam cross-reactivity.

Authors:  Timothy Tattersall; Hugh Wright; Andrew Redmond
Journal:  BMJ Case Rep       Date:  2018-11-28

3.  Meropenem-induced vanishing bile duct syndrome.

Authors:  Annabel L Schumaker; Jason F Okulicz
Journal:  Pharmacotherapy       Date:  2010-09       Impact factor: 4.705

4.  Austrian syndrome.

Authors:  J B Poulsen; C Moser; K Espersen; K Moller
Journal:  BMJ Case Rep       Date:  2011-03-03

5.  Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008.

Authors:  Jessica R MacNeil; Amanda C Cohn; Monica Farley; Raydel Mair; Joan Baumbach; Nancy Bennett; Ken Gershman; Lee H Harrison; Ruth Lynfield; Susan Petit; Arthur Reingold; William Schaffner; Ann Thomas; Fatima Coronado; Elizabeth R Zell; Leonard W Mayer; Thomas A Clark; Nancy E Messonnier
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

Review 6.  Virulence factors and mechanisms of antibiotic resistance of haemophilus influenzae.

Authors:  Tomislav S Kostyanev; Lena P Sechanova
Journal:  Folia Med (Plovdiv)       Date:  2012 Jan-Mar

Review 7.  Coagulopathy of sepsis.

Authors:  Carl-Erik Dempfle
Journal:  Thromb Haemost       Date:  2004-02       Impact factor: 5.249

Review 8.  Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development.

Authors:  Farshid Jalalvand; Kristian Riesbeck
Journal:  Expert Rev Vaccines       Date:  2018-06-18       Impact factor: 5.217

9.  VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE.

Authors:  M Pittman
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

10.  A case of purpura fulminans caused by Hemophilus influenzae complicated by reversible cardiomyopathy.

Authors:  Akira Endo; Atsushi Shiraishi; Junichi Aiboshi; Yoshiro Hayashi; Yasuhiro Otomo
Journal:  J Intensive Care       Date:  2014-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.